Historique
Auteur A. BO
Documents disponibles écrits par cet auteur (18)
Ajouter le résultat à votre sélection Affiner la recherche
E. ALLARA ; M. FERRI ; A. BO ; A. GASPARRINI ; F. FAGGIANO | 2015
Dans BMJ Open (Vol.5, n°9, 2015) Article : PériodiqueObjective: To determine whether there is evidence that mass-media campaigns can be effective in reducing illicit drug consumption and the intent to consume. Design: Systematic review of randomised and non-randomised studies. Methods: We search[...]
M. FERRI ; A. BO | 2013
Dans Drugs: Education, Prevention and Policy (Vol.20, n°4, August 2013) Article : PériodiqueBest practice is the best application of available evidence to current activities in the drugs field. In 2008, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) set off the creation of a web-based tool which bridges together s[...]
The purpose of this paper is to give meaning and insight into some of the key drug and alcohol issues that affect children from the perspectives of the children themselves. It is not to estimate the relative magnitude of a specific drug or alcoh[...]
OEDT = EMCDDA ; J. MOUNTENEY ; M. RUIZ ; A. BO ; T. GROSHKOVA ; J. MATIAS ; L. VANDAM ; F. CARDOSO ; R. CHRISTIE ; L. MONTANARI ; I. GIRAUDON ; P. GRIFFITHS | 2017
RapportThis report provides a first look at the emergence of more problematic forms of use of new psychoactive substances among a range of demographic groups, including opioid and amphetamine injectors, prisoners, the homeless and men who have sex with[...]![Media campaigns for the prevention of illicit drug use in young people [Review]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_77978.webp)
M. FERRI ; E. ALLARA ; A. BO ; A. GASPARRINI ; F. FAGGIANO | 2013
Dans Cochrane Database of Systematic Reviews (n°6, 2013) Article : PériodiqueBackground: Substance-specific mass media campaigns which address young people are widely used to prevent illicit drug use. They aim to reduce use and raise awareness of the problem. Objectives: To assess the effectiveness of mass media campaig[...]Nouveauté
A. PIRONA ; A. BO ; D. HEDRICH ; M. FERRI ; N. VAN GELDER ; I. GIRAUDON ; L. MONTANARI ; R. SIMON ; J. MOUNTENEY | 2017
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : PériodiqueBackground: The availability of new psychoactive substances (NPS) in Europe has rapidly increased over the last decade. Although prevalence levels of NPS use remain low in the general European population, there are serious concerns associated wi[...]Nouveauté
J. MOUNTENEY ; P. GRIFFITHS ; A. BO ; A. CUNNINGHAM ; J. MATIAS ; A. PIRONA | 2018
Dans International Journal of Drug Policy (Vol.51, January 2018) Article : PériodiqueThis paper explores the recent resurgence in use of ecstasy/MDMA in Europe and highlights keys areas of continuity and divergence between the ecstasy market of the 1990s and the current MDMA market. Based on a scoping study involving a targeted [...]
Parent-based interventions on adolescent alcohol use outcomes: A systematic review and meta-analysis
A. BO ; A. H. HAI ; J. JACCARD | 2018
Dans Drug and Alcohol Dependence (Vol.191, October 2018) Article : PériodiqueBackground: The effects of parent-based interventions on adolescent alcohol use are unclear, including what factors moderate intervention effects. This study examines the effects of parent-based interventions on adolescent alcohol use and whethe[...]
Illicit opioid consumption during pregnancy brings with it the risk of an increase in obstetric complications for the mother and a range of potential dangers for the child, both before and after birth. The primary goal when treating opioid depen[...]Nouveauté
M. FERRI ; S. DIAS ; A. BO ; D. BALLOTTA ; R. SIMON ; G. CARRA | 2018
Dans Drugs: Education, Prevention and Policy (Vol.25, n°2, April 2018) Article : PériodiqueBackground: The EMCDDA, through its network of National Focal Points, collects information on the quality assurance systems for drugs-related interventions across European countries. European National Drug Strategies include recommendations for [...]
OEDT = EMCDDA ; J. MOUNTENEY ; A. BO ; A. CUNNINGHAM ; I. GIRAUDON ; J. MATIAS ; A. PIRONA ; N. VAN GELDER ; A. RYBARSKA ; L. VANDAM ; P. GRIFFITHS | 2016
RapportThis report explores the recent resurgence in use of MDMA in Europe and increased availability of high-strength MDMA tablets, crystals and powders. It notes that the picture is not uniform across European countries, and while overall the region’[...]
Objectif drogues, n°23 - Juillet 2012 - Réduction de la demande de drogue : preuves scientifiques mondiales pour actions locales
FRANÇAIS : La mise en place de politiques de réduction de la demande de drogue fondées sur des éléments de preuve scientifique est un objectif essentiel de la politique antidrogue aussi bien au niveau national, qu’à celui de l’Union européenne [...]
G. BURKHART ; V. A. GYARMATHY ; A. BO | 2011
Dans Drugs: Education, Prevention and Policy (Vol.18, n°6, December 2011) Article : PériodiqueFollowing the 2003 publication of the European Union (EU) Council Recommendations and the 2005-2008 and 2009-2012 EU Drugs Action Plans, increasing attention has been given in EU member states’ drug policies to populations that are vulnerable to[...]![Slow-release oral morphine as maintenance therapy for opioid dependence [Protocol]](https://bdoc.ofdt.fr/thumbnail.php?type=1&id=72565)
M. FERRI ; S. MINOZZI ; L. AMATO ; A. BO ; M. DAVOLI | 2012
Dans Cochrane Database of Systematic Reviews (n°5, 2012) Article : PériodiqueThis is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the efficacy of slow-release oral morphine (SROM) as an alternative maintenance pharmacotherapy for the treatment of opioid dependence.
FRANÇAIS : Comment fonctionnent les marchés des drogues en ligne ? Quelles technologies utilisent-ils ? Quelles relations entretiennent-ils avec le marché traditionnel des drogues ? Comment peuvent-ils être surveillés et contrôlés ? Depuis u[...]
